Menopause Symptom Management

Vasomotor Symptoms (Hot Flashes)

The American College of Oncology recommends SNRIs, such as venlafaxine, as a safe and effective option for reducing hot flashes, decreasing their intensity and severity by approximately 40-65% 1
SSRIs can decrease vasomotor symptoms, though there is concern that some SSRIs may reduce the conversion of tamoxifen to active metabolites 1
Gabapentin has been shown to be effective in reducing hot flashes and may be considered as an alternative option 1
Lifestyle modifications, including rhythmic breathing, exercise, and avoiding triggers, can help manage symptoms, as suggested by the Annals of Oncology 3
Environmental modifications, such as maintaining cool room temperatures and dressing in layers, can provide relief, according to the Annals of Oncology 3
Acupuncture has shown some efficacy in reducing menopausal symptoms and hot flashes in meta-analyses of RCTs, as reported by the Journal of Clinical Oncology 1

Low-dose vaginal estrogen preparations can improve genitourinary symptom severity by 60-80% with minimal systemic absorption, as recommended by the Praxis Medical Insights 2
Silicone-based lubricants may last longer than water-based or glycerin-based products for vaginal dryness, according to the Journal of Clinical Oncology 1
Vaginal moisturizers can be used as non-hormonal alternatives, with a reduction in symptom severity of up to 50%, as suggested by the Praxis Medical Insights 2
Treating dyspareunia with vaginal dilators or pelvic floor relaxation techniques may be helpful, as reported by the Journal of Clinical Oncology 1

The American Academy of Family Physicians recommends that systemic hormone therapy should be used at the lowest effective dose for the shortest possible time if needed for severe symptoms 5
For women with an intact uterus, combination estrogen and progestin therapy is required to prevent endometrial cancer, as recommended by the Praxis Medical Insights 2
For women without a uterus, estrogen-alone therapy can be used, according to the Praxis Medical Insights 2
Transdermal routes of HRT administration are preferred as they have less impact on coagulation, as suggested by the Praxis Medical Insights 2

The American Academy of Family Physicians reports that HRT is associated with increased risks including CHD events, stroke, pulmonary emboli, and invasive breast cancer 5
Benefits include reduction in osteoporosis and fractures by approximately 30-50%, as reported by the Praxis Medical Insights 2
At age 56, the absolute increase in risk from hormone therapy is modest but should be carefully weighed against potential benefits for symptom relief, according to the Praxis Medical Insights 2

The American Academy of Family Physicians indicates that hormone therapy is indicated primarily for symptom management, not for prevention of chronic conditions 5
Complementary and alternative treatments generally lack strong evidence of efficacy and may have safety concerns, as reported by the Annals of Oncology 3
High-dose vitamin E has shown limited efficacy for mild vasomotor symptoms, but doses >400 IU/day have been linked with increased all-cause mortality, according to the Annals of Oncology 3
For women with a history of breast cancer, hormonal therapies should be used with caution or avoided, particularly for those on aromatase inhibitors, as recommended by the Journal of Clinical Oncology and the Annals of Oncology 1, 3